Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

87.2K
Overview
87.2K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.3K
The Blood-brain Barrier00:49

The Blood-brain Barrier

47.4K
Overview
47.4K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation01:37

Neural Regulation

39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery.

Nature biotechnology·2026
Same author

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
Same author

Enhanced glymphatic CSF tracer influx during α2-adrenergic agonist anesthesia is independent of tracer injection duration.

bioRxiv : the preprint server for biology·2026
Same author

Extending the glymphatic system beyond the brain: The Cochlear aqueduct as a neuroimmune gateway to the inner ear.

Neurobiology of disease·2026
Same author

Chronotherapy to reinforce circadian rhythms improves poststroke outcomes and glymphatic function in mice.

The Journal of clinical investigation·2026
Same author

Asymmetric Optic Disc Edema in Astronauts: A Narrative Review Proposing an Interplay Between Ocular Venous Congestion and Glymphatic Transport.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 3, 2025

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy
06:22

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy

Published on: July 29, 2019

13.8K

Glymphatic system dysfunction in neurodegenerative diseases.

Natalie Beschorner1, Maiken Nedergaard1,2

  • 1Center for Translational Neuromedicine, Faculty of Medical and Health Sciences, University of Copenhagen, Copenhagen N, Denmark.

Current Opinion in Neurology
|February 12, 2024
PubMed
Summary
This summary is machine-generated.

Glymphatic fluid transport is suppressed in neurodegenerative diseases like Alzheimer's disease. Future research aims to understand the mechanisms and diagnostic potential of glymphatic imaging for treatment.

More Related Videos

Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy
10:05

Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy

Published on: May 22, 2020

10.2K
Cannula Implantation into the Cisterna Magna of Rodents
10:13

Cannula Implantation into the Cisterna Magna of Rodents

Published on: May 23, 2018

44.8K

Related Experiment Videos

Last Updated: Jul 3, 2025

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy
06:22

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy

Published on: July 29, 2019

13.8K
Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy
10:05

Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy

Published on: May 22, 2020

10.2K
Cannula Implantation into the Cisterna Magna of Rodents
10:13

Cannula Implantation into the Cisterna Magna of Rodents

Published on: May 23, 2018

44.8K

Area of Science:

  • Neuroscience
  • Neurology
  • Biomedical Engineering

Background:

  • Glymphatic system dysfunction is increasingly implicated in neurodegenerative diseases.
  • Studies consistently show impaired brain fluid transport in Alzheimer's disease patients compared to controls.

Approach:

  • Review of preclinical models and clinical neuroimaging studies on glymphatic function in Alzheimer's disease.
  • Analysis of current research on the mechanisms underlying glymphatic suppression.

Key Points:

  • Glymphatic fluid transport is broadly suppressed in neurodegenerative conditions.
  • Alzheimer's disease models and human studies demonstrate impaired brain fluid clearance.
  • Open questions remain regarding the mechanistic basis and diagnostic applications of glymphatic imaging.

Conclusions:

  • Glymphatic system impairment is a significant hallmark of neurodegenerative diseases, particularly Alzheimer's.
  • Further research into the mechanisms of glymphatic suppression is crucial.
  • Glymphatic imaging holds promise for diagnostics and therapeutic strategies in Alzheimer's disease.